Omega Healthcare Investors, Inc. (NYSE:OHI) is trading up 25.24% versus 12-month low of 25.55 and stands -14.37% lower from its 1-year peak of $37.37. The consensus price target (PT) of $34.44 means that the market expects Company shares to increase by 6.3% in the short run. The sell-side target prices range from $25 to $40. In the last month the stock has moved in price 3.36%, with a one year change of -1.73%. The last trading session volume compares with the 2.48M average and market worth floats around 6.23B.

Omega Healthcare Investors, Inc. (NYSE:OHI) fell -1.23% to reach at the trading price of $32.00 as it is set to release its next quarterly earnings report on February 13, 2017. Omega Healthcare Investors, Inc. stock trades in the range of $31.86 to $32.49 before the earnings release. Let’s take a closer look at the current earnings forecast, particularly the things traders should pay close attention to. Earnings per share for the recently concluded quarter is expected to come in at $0.48 a share with $195.14M in revenue.

Omega Healthcare Investors, Inc. (OHI) Future Earnings & History

After upcoming fiscal quarter results, all eyes will be on the prospects for the next reporting quarter. Analysts, on average, forecast Omega Healthcare Investors, Inc. to earn $0.52 per share (EPS) on revenue of $195.7M. The EPS consensus range is $0.51-$0.52 on revenue between $204.23M and $180.84M.

While if we look at the Earnings Track Record, Omega Healthcare Investors, Inc. (OHI) managed to surpass quarterly earnings per share estimates in 9 of the trailing twelve fiscal quarters, and has a positive trend with an average surprise of 75%. Revenues hit $185.84M in the September 2017 quarter, which was below the consensus $186.35M projection. On the other hand, in the June 2017 quarter the company recorded a net $186.45M revenue.

Omega Healthcare Investors, Inc. (NYSE:OHI) Analyst Insights

The buoyancy in the outlook of Omega Healthcare Investors, Inc. (OHI) is getting weaker by the somewhat negative sentiment (2.50 on a 5-point scale) that sell-side analysts have provided concerning it. Brokerage firms on the average advocate the company shares as Buy. Jefferies has been covering shares of OHI, so it is most recent view is worth a look. In a research note issued on Aug 18, 2016, analysts at downgraded the stock to Mkt Perform from Mkt Outperform. Another noteworthy analyst activity was recorded on Feb 25, 2016. Jefferies Analysts lifted the stock to Buy from Hold.